P16 and p27 tumor suppressor gene methylation status in childhood Wilms tumor cases;Çocukluk çaǧı wilms tümör olgularında p16 ve p27 tümör süpressör gen metilasyon durumu

Turkish Journal of Medical Sciences

Volumn 41, Issue 4, 2011, Pages 633-638

  Bozkurt, Ceyhun ^a   Bozkurt, Süeyya ^b   Arda, Nilüer ^a   Ertem, Ayşe Ulya ^a   Şahin, Güses ^a   Yüksek, Nazmiye ^a   Güç, Dicle ^b   Kansu, Emin ^b  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Epigenetic; Methylation; P16 gene; P27 gene; Wilms tumor

Indexed keywords

GENOMIC DNA;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MALE; NEPHROBLASTOMA; P27 GENE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROMOTER REGION; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

EID: 79960877139     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-0909-296     Document Type: Article

References (30)

1. Feinberg AP. The Epigenetic of cancer etiology. Semin Cancer Biol 2004; 14: 427-32.
2. Singal R, Ginder GD. DNA methylation. Blood 1999; 93: 4059-70.
3. Tsellou E, Troungos C, Moschovi MP, Athanasiadou- Piperopoulou F, Polychronopoulou S, Kosmidis H et al. Hypermethylation of CpG island in the promoter region of the p15INK4b gene in childhood acute leukemia. Eur J Cancer.2005; 41: 584-9.
4. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG et al. Growth Suppressor by p18, p16 INK4/MTS1 and p14 INK4B/MTS2 related CDK6 inhibitor correlates wildtype pRb function. Genes Dev 1994; 15: 2939-52.
5. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995; 6: 387-400.
6. Lowe SW, Sherr CJ. Tumor suppression by INK4a-Arf: Progress and puzzles. Curr Opin Genet Dev. 2003; 13: 77-83.
7. Auerkari EI. Methylation of tumor suppressor genes p16 (INK4a), p27 (Kip1) and E-cadherin in carcinogenesis. Oral Oncol 2006; 42: 5-13.
8. Baylin SB, Chen WY. Aberrant gene silencing in tumor progression: implications for control of cancer. Cold Spring Harb Symp Quant Biol 2005; 70: 427-33.
9. Matsuda Y. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. World Gastroenterol 2008; 14: 1734-40.
10. Nakamuro M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K et al. Frequent alterations of the p14 (ARF) and p16 (INK4a) genes in primary central nervous system lymphomas. Cancer Res 2001; 61: 6335-6339.
11. Herman GJ, Graff RJ, Myohanen S, Nelkin BD, Baylin SB. Methylation specific PCR: a novel PCR assay for methylation status of CPG islands. Proc Natl Acad Sci 1996; 93: 9821-6.
12. Kanai Y. Alteration of DNA methylation and clinicopathological diversity of human cancers. Pathology International 2008; 58: 544-58.
13. Gronbaek K, Hother C, Jones PA. Epigenetic changes in cancer. APMIS 2007; 115: 1039-1059.
14. Goldstein M, Meller I, Orr-Urtreger A. FGFR 1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5' CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes. Genes Chromosomes Cancer 2007; 46: 1028-38
15. Watanabe M, Ogawa Y, Itoh K, Koiwa T, Kadin ME, Watanabe T et al. Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma. Lab Invest 2008; 88: 48-57.
16. Nishyama R, Qi L, Lacey M, Ehrlich M. Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer. Mol Cancer Res 2005; 3: 617-26.
17. Erlich M, Jiang G, Fiala E, Dome JS, Yu MC, Long TI et al. Hypomethylation and hypermethylation of DNA in Wilms tumor. Oncogene 2002; 21: 6694-702.
18. Sanchez-Beato M, Saez AI, Navas IC, Algara P, Sol Mateo M, Villuendas R et al. Overall survival in aggressive B-cell lymphoma is dependent on the accumulation of alterations in p53, p16, and p27. Am J Pathol 2001; 159: 205-13.
19. Chim S, Fung TK, Wong KF, Lau JS, Law M, Liang R et al. Methylation of INK4 and CIP/KIP families of Cyclindependent kinases inhibitor in chronic lymphocytic leukemia in Chinese patients. J Clin Pathol 2006; 59: 921-926.
20. Nakayama G, Hibi K, Kodera Y, Koike M, Fujiwara M, Nakao A et al. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma. Anticancer Res 2007; 27: 3367-70.
21. Kawauchi S, Liu XP, Kawasaki K, Hirakawa T, Amada S, Furuya T et al. Significance of beta catenin and PRB pathways components in malignant ovarian germ cell tumors: INK4A promoter CpG island methylation is associated with cell proliferation. J Pathol 2004; 204: 268-76.
22. Qian X, Jin L, Kulig E, Lloyd RV. DNA methylation regulates p27 kip1 expression in rodent pituitary cell lines. Am J Pathol 1998; 153: 1475-83.
23. Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M et al. Anaplastic Wilms' tumor, a subtype displaying poor prognosis, harbors p53 gene mutations. Nat Genet 1994; 7: 91-7.
24. Vidaurreta M, Maestro ML, Sanz-Casla MT, Maestro C, Rafael S, Veganzones S et al. Inactivation of p16 by CpG hypermethylation in renal cell carcinoma. Urol Oncol. 2008; 26: 239-45.
25. Arcellana-Panlilio MY, Egeler RM, Ujack E, Pinto A, Demetrick DJ, Robbins SM et al. Decreased expression of the INK4 family of Cyclin-dependent kinases inhibitors in Wilms tumor. Genes Chromosomes Cancer 2000; 29: 63-9.
26. Faussillon M, Monnier L, Junien C, Jeanpierre C. Frequent over expression of Cyclin D2/Cyclin-dependent kinases 4 in Wilms' tumor. Cancer Lett 2005; 221: 67-75.
27. Morris MR, Hesson LB, Wagner KJ, Morgan NV, Astuti D, Lees RD et al. Multigene methylation analysis of Wilms' tumor and adult renal cell carcinoma. Oncogene 2003; 22: 6794-801.
28. Brakensiek K, Langer F, Kreipe H, Lehmann U. Absence of p21 (CIP1), p27 (KIP1) and P57 (KIP2) methylation in MDS and AML. Leuk Res 2005; 29: 1357-60.
29. Chim CS, Wong ASY, Kwong YL. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias. Am J Hematol 2005; 80: 282-7.
30. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K et al. PKB/Akt phosphoraletes p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002; 8: 1153-60.